Chlorpromazine Hydrochloride Tablet, Film Coated
Product Images NDC 16714-051

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Chlorpromazine Hydrochloride (NDC 16714-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (C42f24dc C78e 45eb Beaf 59cb72450b82 01)

FDA Label Image

Label (C42f24dc C78e 45eb Beaf 59cb72450b82 02)

FDA Label Image

Label (C42f24dc C78e 45eb Beaf 59cb72450b82 03)

This is a description of Chlorpromazine Hydrochloride Tablets, USP with 25mg dosage per tablet. It contains 100 tablets per container and is used for prescription purposes. It should be stored in a dry, cool place with no light and moisture. The drug is manufactured by Northstar and Cadia Healthcare Ltd in India. The text also includes safety instructions to keep it away from children.*

FDA Label Image

Label (C42f24dc C78e 45eb Beaf 59cb72450b82 04)

Each film-coated tablet contains 50mg of Chlorpromazine hydrochloride, which should be protected from light and moisture. The tablet comes in a light-resistant container with a child-resistant cap. The standard dose must be verified from the package. The drug is manufactured by Cadila Healthcare Ltd., India, and distributed by Northstar RxLLC located in Memphis, Tennessee. No other valuable information is available in the text.*

FDA Label Image

Label (C42f24dc C78e 45eb Beaf 59cb72450b82 05)

This is a description of ChlorproMAZINE Hydrochloride in the form of tablets. It contains 100mg of GhrlorproMAZINE hycrochloride, USP in each tablet and is intended to be used only in severe neuropsychiatric conditions. It is advised to refer to the package insert for complete prescribing information. It should be stored in a cool and dry place, away from light and moisture. Dispensing should be done in a light-resistant container with a resistant closure. This drug should be kept out of the reach of children. The product is manufactured by Cadia Healthcare Ltd in India, and distributed by Norhster Rx LLG in Memphis, TN, USA.*

FDA Label Image

Label (C42f24dc C78e 45eb Beaf 59cb72450b82 06)

This is a drug label for Chlorpromazine Hydrochloride tablets, with a strength of 200mg. It is intended for use in severe neuropsychiatric conditions only. The recommended dosage is not provided, and the label advises to refer to the package insert for complete prescribing information. The tablets should be stored at controlled room temperature and protected from light and moisture. The label also includes manufacturing information and a warning to keep all drugs out of the reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.